China Palonosetron Hydrochloride injection ampoule Manufacturers Factory Suppliers
-
Palonosetron Hydrochloride Injection– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3, Palonosetron Hydrochloride Injection 0.25mg/5ml, 0.075mg/1.5ml
Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
-
RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material, Registered As An Implanted Medical Device, Tablet (vial): 1mg/vial
Chemical Name: Recombinant Human Bone Morphogenetic Protein-2. A new type bone repairing material which has biological activity..
-
RhIL-11 Injection(Oprelvekin), CAS No.: 145941-26-0, (Recombinant Human Interleukin-11) – A Drug To Increase Platelet Count, RhIL-11 Injection Lyophilized Powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial
Generic Name: Oprelvekin. Trade Name: JIJUFEN. Chemical Name: Human Interleukin-11 for Injection. The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced
-
RhG-CSF Injection(Filgrastim) (Recombinant Human Granulocyte Colony-Stimulating Factor) – A Drug To Increase White Blood Cell Count, CAS No.: 121181-53-1
Generic Name: Filgrastim. Trade Name: JILIFEN. Chemical Name: Human Granulocyte-Colony Stimulating Factor (hG-CSF) Injection.
-
Fulvestrant– An Anti-cancer Drug ,CAS No.: 129453-61-8
Fulvestrant is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic).
-
Daratumumab (with Recombinant Human Hyaluronidase)injection, CAS No.: 945721-28-8
Name: Daratumumab (with recombinant human hyaluronidase). CD38 inhibitor with recombinant human hyaluronidase. INDICATIONS: Multiple myeloma
-
SIRPα- Specific Monoclonal Antibody
Name: SIRPα. - Specific monoclonal antibody. INDICATIONS: Solid tumors
-
Romosozumab Injection - Osteoporosis, CAS: 909395-70-6
Name: Romosozumab injection . Sclerostin inhibitor. INDICATIONS: Osteoporosis
-
Fulvestrant Injection– An Anti-cancer Drug,CAS No.: 129453-61-8, Bulk and Injection (PFS): 250mg in 5ml
Fulvestrant is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic).
-
PegFilgrastim Injection– A Long Lasting RhG-CSF, CAS No.: 208265-92-3,Bulk and Injection (PFS): 6mg in 0.6ml
Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection, by treating
-
Fosaprepitant Dimeglumine Injection, CAS No.: 265121-04-8,Bulk and Injection(vial)150mg/5ml
Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
-
Daratumumab Injection - Multiple Myeloma (CD-38 Mab), CAS No.: 945721-28-8
Hangzhou Jiuyuan is a top-biotech joint venture specializing in the research, development, manufacture, and marketing of pharmaceuticals based on gene engineering and biochemical technology since
Palonosetron HCl Injection is sterile, clear, and colorless solution: 0.25 mg palonosetron in 5 mL (0.05 mg/mL) in a single-dose vial 0.075 mg palonosetron in 1.5... Read more Did you find an...
Palonosetron HCL injection 0.25mg/5m, 0.075mg/1.5ml. 0.25mg/5m, 0.075mg/1.5ml Category: Finished Dosage Tag: MedrivaFinished Dosage Tag: Medriva...
11 rows · Palonosetron Hydrochloride Injection 0.25mg/5ml Technical Specification: Product Name: ......
11 rows · Palonosetron Hydrochloride Injection 0.075mg/1.5ml Technical Specification: Product Name: ......
Palonosetron HCl Injection is a sterile, clear, colorless, non-pyrogenic, isotonic, buffered solution for intravenous administration. Palonosetron HCl Injection is available as a 5 mL or 1.5 mL...
0.25 mg palonosetron in 5 mL (0.05 mg/mL) in a single-dose vial ... Of the 138 patients treated with palonosetron HCl injection 0.075 mg and evaluated for efficacy, 96% were women; 66%...
